Bayer won four recent lower-court decisions in favour of Roundup weed killer, but lost a big one when the United States Supreme Court denied the company’s bid to overturn an $87-million award to a California couple who claimed Roundup caused their cancers.
Bayer has argued that the cancer claims over Roundup and its active ingredient glyphosate go against sound science and product clearance from the U.S. Environmental Protection Agency.
Bayer’s appeal in the Pilliod case raised an additional challenge, arguing that it would violate the U.S. Constitution’s due process protections to award punitive damages that far outweigh compensatory damages.